When you hear the term personalized medicine, you might think of a treatment plan designed just for you—and in cancer care, that’s increasingly becoming a reality. Personalized cancer treatment, also known as precision oncology, uses a person’s genetic and molecular profile to tailor treatment strategies to the unique characteristics of their cancer1.
Genes hold the instructions for how cells grow and change. In cancer, certain genes may be mutated or behave abnormally. Understanding these variations has led to the development of more precise diagnostics, more effective therapies, and a new generation of targeted treatments designed to hit cancer at its molecular roots2.
Compared to conventional approaches, personalized treatment may offer fewer side effects and better outcomes because it’s designed with a patient’s specific cancer in mind—not a one-size-fits-all model3.
What Personalized Cancer Treatment Can Include
Personalized cancer care goes beyond just matching a drug to a mutation. It can help guide decisions across the entire journey:
- Identifying your risk of cancer and choosing the right screening tests early
- Tailoring treatment options based on your tumor’s biology and your health goals
- Estimating the likelihood of recurrence—also called recurrence risk—to plan ahead
- Selecting therapies that are more likely to work and less likely to harm healthy cells
These strategies can help people with cancer feel more confident in their care and more supported in their decisions.
What’s Holding Personalized Treatment Back?
While the science is promising, access to personalized care still has gaps:
- Not all cancers have well-defined targets for personalized therapies
- Some treatments are only available through clinical trials
- Genetic testing can be expensive and isn’t always covered by insurance
- There may be delays between testing and treatment, and some therapies come at a higher cost4
Still, the field is moving quickly. As researchers identify new targets and develop more affordable testing, these options are becoming available to more people with cancer every year.
Where Personalized Treatment Is Already Making a Difference
Targeted therapies are now available for a wide range of cancers, including breast, lung, colorectal, kidney, and liver cancers—as well as leukemia, GIST, and others5. These treatments work by interfering with specific genes or proteins that fuel cancer growth. When they work, they can shrink tumors, extend life, and improve quality of life with fewer side effects than traditional chemotherapy.
But it’s important to note: even the most advanced personalized treatment might not be effective for every patient. Tumors are complex and may evolve to resist targeted therapy. That’s why expert guidance is critical to understanding your options and making informed decisions.
How Ardynn Can Help
At Ardynn, we help people with cancer understand their treatment options in the context of their own lives, values, and goals. Our advocates use personalized data from real-world patients—people just like you—to support shared decision-making and help you explore what matters most. From understanding recurrence risk to weighing treatment trade-offs, we’re here to guide the whole person, not just the disease.
Have questions? We’re here for you. To get started with an advocate, contact Ardynn member services at 737-307-0077 or click here to schedule an introductory call.
